Valuation: Cencora, Inc.

Market Cap 59.89B 51.72B 48.6B 44.2B 83.1B 5,726B 84.47B 569B 223B 2,868B 225B 220B 9,529B P/E 2026 *
17.2x
P/E 2027 * 18.8x
Enterprise Value 67.57B 58.36B 54.84B 49.87B 93.77B 6,461B 95.31B 643B 251B 3,236B 254B 248B 10,752B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.2x
Free-Float
61.21%
Yield 2026 *
0.76%
Yield 2027 * 0.78%
1 week-2.09%
Current month+0.86%
1 month+3.86%
3 months+20.23%
6 months-12.97%
Current year-7.01%
1 week 302.64
Extreme 302.635
333.91
1 month 296.4
Extreme 296.4
333.91
3 years 172.18
Extreme 172.18
377.47
5 years 114.05
Extreme 114.05
377.47
10 years 68.4
Extreme 68.4
377.47
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2024
Director of Finance/CFO 59 29/06/2026
Chief Tech/Sci/R&D Officer 50 04/11/2024
Director TitleAgeSince
Director/Board Member 75 16/05/2013
Director/Board Member 59 01/10/2024
Chairman 64 01/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
+1.44%-4.61%+6.44%+67.42% 59.89B
-0.02%+3.19%-15.56%+6.43% 193B
+0.76%+4.72%-1.88%+11.89% 117B
+1.43%-2.07%+7.17%+70.56% 59.89B
-1.33%+0.15%+34.00%+70.27% 56.01B
+0.79%+3.70%-6.40%-33.73% 49.96B
-1.89%+5.90%+10.87%-19.26% 33.87B
+0.45%+1.45% - - 31.36B
-1.63%+1.98%-5.81%+27.87% 24.77B
+0.94%-1.31%+41.93%-12.09% 24.59B
Average -0.07%+3.65%+7.86%+21.04% 65.53B
Weighted average by Cap. +0.11%+3.37%+0.71%+20.83%

Financials

2026 *2027 *
Net sales 337B 291B 274B 249B 468B 32,236B 476B 3,206B 1,253B 16,143B 1,266B 1,238B 53,645B 355B 307B 288B 262B 493B 33,970B 501B 3,378B 1,321B 17,011B 1,334B 1,305B 56,530B
Net income 3.58B 3.09B 2.91B 2.64B 4.97B 342B 5.05B 34.05B 13.31B 171B 13.44B 13.15B 570B 2.84B 2.46B 2.31B 2.1B 3.95B 272B 4.01B 27.06B 10.58B 136B 10.68B 10.45B 453B
Net Debt 7.68B 6.64B 6.24B 5.67B 10.66B 735B 10.84B 73.07B 28.57B 368B 28.85B 28.22B 1,223B 9.44B 8.15B 7.66B 6.97B 13.1B 902B 13.31B 89.74B 35.09B 452B 35.43B 34.66B 1,502B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
-
Date Price Change
14/08/26 USD 314.06 +1.25%
13/08/26 USD 310.19 -1.22%
12/08/26 USD 314.02 -5.96%
11/08/26 USD 333.91 +2.71%
10/08/26 USD 325.11 +1.35%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
313.82USD
Average target price
372.58USD
Spread / Average Target
+18.73%

Quarterly revenue - Rate of surprise